The following is a summary of “Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy,” published in the January 2025 issue of ...

The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...

A 2010 study examined three randomized controlled trials involving 78 people with symptomatic diabetic peripheral neuropathy. Researchers found that average pain scores were significantly reduced ...

This can happen to people with either type 1 or type 2 diabetes. The type of neuropathy that causes burning feet is called peripheral neuropathy, which is the most common type of neuropathy.

The FDA approves Vertex's non-opioid oral pain signal inhibitor, Journavx, for treating adults with moderate-to-severe acute pain. Shares rise.

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

There are over 100 different kinds of peripheral neuropathy, most of which are polyneuropathies. Risk factors and causes of polyneuropathy can include diabetes, alcohol misuse, and certain ...

The following is a summary of “Correlation between high-sensitivity cardiac troponin levels in diabetic patients’ serum and ...

Leerink Partners analyst David Risinger has reiterated their bullish stance on VRTX stock, giving a Buy rating yesterday.Invest with ...